American Century Companies’s Co-Diagnostics CODX Stock Holding History
Bought
Maintained
Sold
Other funds holding CODX
BCM
KAS
KOC
American Century Companies's CODX Position: Q3 2023 in Review
American Century Companies sold out of Co-Diagnostics (CODX) in Q3 2023, closing a stake of 380 shares — an estimated $12.6K sold.
American Century Companies first reported a position in CODX in Q4 2021 and held it in 7 quarters. The position peaked at $598K in Q3 2022. 43 funds tracked by Wall St. Rank hold CODX as of Q3 2023.
- American Century Companies reported no remaining Co-Diagnostics position as of Q3 2023 after selling out during the quarter.
- American Century Companies sold 380 Co-Diagnostics shares in Q3 2023, an estimated $12.6K.
- American Century Companies first reported a position in Co-Diagnostics in Q4 2021 and held it in 7 quarters.
- American Century Companies's Co-Diagnostics position peaked at $598K in Q3 2022.
- 43 funds tracked by Wall St. Rank held Co-Diagnostics as of Q3 2023.
Based on American Century Companies's 13F filing for Q3 2023, filed 13 Nov 2023.